Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05138874 · ClinicalTrials.gov registry record · NA

Improving Safe Antibiotic Prescribing in Telehealth

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
6,581
Enrollment target

NCT05138874 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 6,581 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05138874, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
6,581 participants
Enrollment target

Study Summary

Appropriate use of antibiotics reduces resistance and protects patients from unnecessary harm. Important advances in antibiotic stewardship have been achieved in outpatient settings, but little is known about stewardship in the rapidly growing telehealth sector. Prior pragmatic randomized trials have shown that Centers for Disease Control (CDC) Core Element interventions constructed using insights from decision and social psychology can greatly reduce inappropriate prescribing in outpatient settings. In a randomized trial, the investigators will adapt and test two aspects of CDC Core Elements in a telehealth environment (Teladoc®), each with two levels of intensity. Teladoc® clinicians will be randomized to the following interventions: 1) Performance Feedback (Trending, Benchmark Peer Comparison), 2) Commitment (Private, Public), or 3) Control. All randomization occurs at the provider level, with the exception of the Public Commitment arm, which requires patient-facing content that is determined by patient state. Clinicians and members will see the same messages across all pages, all channels \& all consults during the 12-month study period. The primary outcome is to assess change in antibiotic prescribing rate for qualifying acute respiratory infection visits (ARIs).

Interventions

  • BEHAVIORAL Trending Feedback
  • BEHAVIORAL Benchmark Peer Comparison Feedback
  • BEHAVIORAL Private Commitment
  • BEHAVIORAL Public Commitment

Trial Details

FieldValue
Enrollment Target 6,581 participants
Start Date 2022-03-03
Est. Completion 2023-09-21
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT05138874

The ClinicalTrials.gov registry entry for NCT05138874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,581 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Trending Feedback is the first listed.

NCT05138874 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05138874 about?

NCT05138874 is a clinical study titled "Improving Safe Antibiotic Prescribing in Telehealth". Appropriate use of antibiotics reduces resistance and protects patients from unnecessary harm. Important advances in antibiotic stewardship have been achieved in outpatient settings, but little is known about stewardship in the rapidly growing telehealth sector. Prior pragmatic randomized trials hav...

What is the current status of trial NCT05138874?

This trial is currently completed. It is a NA study. The enrollment target is 6,581 participants. The study started on 2022-03-03. Estimated completion is 2023-09-21.

What interventions are being tested in trial NCT05138874?

The interventions under investigation include: Trending Feedback (BEHAVIORAL), Benchmark Peer Comparison Feedback (BEHAVIORAL), Private Commitment (BEHAVIORAL), Public Commitment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05138874?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.